Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)Luca Durelli, Mauro Zaffaroni, E. Verdun et al.|The Lancet|2002Cited by 552
Liver and thyroid function and autoimmunity during interferon-β1b treatment for MSLuca Durelli, Bruno Ferrero, Alessandra Oggero et al.|Neurology|2001Cited by 55
Thyroid Function and Autoimmunity during Interferon β-1b Treatment: A Multicenter Prospective StudyLuca Durelli, Mauro Zaffaroni, Bruno Ferrero et al.|The Journal of Clinical Endocrinology & Metabolism|2001Cited by 47
Autoantibodies in Multiple Sclerosis Patients Before and During IFN- <i>β</i> 1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?E. Verdun, Luca Durelli, E. Montanari et al.|Journal of Interferon & Cytokine Research|2002Cited by 31